Fortune has the best coverage of the Thursday opening statements, and notes the contrast between the opening statements of plaintiff’s attorney Mark Lanier, which was illustrated by pictures of a steamroller and a shell game, and Merck attorney David C. Kiernan, which the magazine seems to think made a mistake in respecting the intelligence of the jury by relying on the science behind the case instead of folksy name-calling. “If the company hoped to win points with the public for erring on the side of safety—its stated public rationale for having pulled the drug—the wager may have been naïve.” And if plaintiffs’ attorneys succeed in punishing Merck for taking safety measures, it’s bound to reduce safety in the future. Meanwhile, the New York Times publishes a puff piece on the plaintiff widow fed to the newspaper by the attorneys, barely acknowledging that her husband died of an arhythmia rather than a blood clot, and then failing to note that Roger Ernst was just one of 200,000 victims a year of fatal atherosclerosis (except in the small print of a photo of the coroner’s certificate), and thus was not “healthy and fit” regardless of whether he was a triathlete. The Times reveals a rogues’ gallery of plaintiffs’ lawyers helping out Lanier, without giving any indication of their unseemly background: Benedict Morelli (Nov. 23, 2003) and Fred Baron’s wife, Lisa Blue of Baron & Budd (Jul. 15, 2004; Jun. 17, 2004 and links therein). (Roger Parloff, “Stark Choices at the First Vioxx Trial”, Fortune, Jul. 15; Alex Berenson, “Contrary Tales of Vioxx Role in Texan’s Death”, New York Times, Jul. 15; Alex Berenson, “Jury Is Selected for Case Involving the Drug Vioxx”, New York Times, Jul. 14; Alex Berenson, “In First of Many Vioxx Cases, a Texas Widow Prepares to Take the Stand”, New York Times, Jul. 13; previous Overlawyered coverage: Jul. 1, Jul. 11 (includes my disclaimer), POL Jul. 15). Plaintiffs’ attorney Daniel Keller is liveblogging the trial, albeit not in the most objective fashion. Further coverage: Jul. 29, Aug. 19 ($253 million jury verdict).

Filed under: Fred Baron, Mark Lanier, product liability, Vioxx